SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The community is buzzing around ImmunityBio (IBRX) as founder Dr. Patrick Soon-Shiong appears in highly anticipated prime-time interviews to discuss breakthrough cancer treatments, with investors actively debating the potential for a significant short squeeze and an impactful business update next week that could challenge traditional pharma.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community rallies around the approaching 4/20, emphasizing a long-term "culture coin" vision for the cannabis ecosystem, even as discussions arise regarding its sustainability versus pump-and-dump characteristics.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is surging following a strong earnings beat and upbeat guidance for AI/data center demand for its 400G and 800G transceivers, alongside significant analyst price target upgrades. The rally is fueled by short-squeeze momentum and optimism for future growth, though community discussion also reflects concerns over the company's valuation and a recent equity offering.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF ($VTI) is generating significant discussion as a bellwether for the U.S. market, with investors observing strong inflows and its proximity to all-time highs. The community is weighing these positive signals against prevailing political and economic uncertainties, prompting ongoing debate about diversification and market direction.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is a hot topic amid mixed sentiment following its earnings report, which highlighted robust revenue growth and new defense contracts, but also confirmed a Neutron rocket launch delay into late in the year. While the community is enthusiastic about the company's expanding defense role and broader space industry tailwinds, concerns linger regarding the extended Neutron timeline.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending amid discussions surrounding its renewed bid to merge NBCUniversal with Warner Bros. Discovery, a strategic move generating debate about its potential to create a media powerhouse or add debt. The impending spin-off of Versant Media Group is also a key talking point, with investors anticipating it will clarify valuation and focus on Comcast's core connectivity and entertainment assets.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is trending as it halted its Phase 3 trial for ARD-101, its Prader-Willi Syndrome treatment, following reports of reversible cardiac safety signals. The community is actively discussing this significant setback, calling it a disaster and questioning the company's future in the competitive PWS treatment landscape.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is witnessing intense trading and volatility, as the broader AI infrastructure sector reacts to a competitor's recent earnings, prompting strong debate among investors. The community is emphasizing NBIS's robust fundamentals and contrasting it with the perceived weaknesses of its peers.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending after a strong Q4 earnings beat, which included GAAP profitability and robust 2026 guidance driven by numerous new enterprise deals and impressive revenue growth. Despite these positive fundamentals, community sentiment expresses frustration over the stock's flat or declining price, with many blaming market manipulation by a significant short interest while long-term investors accumulate shares, confident in its AI leadership.

Red Robin Gourmet Burgers, Inc. develops, operates, and franchises full-service restaurants North America. It serves a variety of salads, soups, appetizers, other entrees, desserts, signature alcoholic and non-alcoholic beverages. The company was founded in September 1969 and is headquartered in Englewood, CO.

Red Robin Gourmet Burgers Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 10.7% After Earnings Beat

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading 10.7% Higher on Better-Than-Expected Earnings...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen analysts that are presently covering the stock...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Posts Quarterly Earnings Results, Beats Expectations By $1.05 EPS

BioCryst Pharmaceuticals (NASDAQ:BCRX - Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $1.12 earnings per share (EPS) for the quarter, beating...

BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of +1,623.08% and +172.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BioCryst Pharmaceuticals Q4 Earnings Call Highlights

BioCryst Pharmaceuticals (NASDAQ:BCRX) outlined its full-year 2025 performance and priorities for 2026 during its fourth-quarter conference call, highlighting strong growth for its hereditary...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up After Better-Than-Expected Earnings

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up on Strong Earnings...

Harrow (HROW) Reports Next Week: Wall Street Expects Earnings Growth

Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Public Sector Pension Investment Board Takes $2.01 Million Position in BioCryst Pharmaceuticals, Inc. $BCRX

Public Sector Pension Investment Board purchased a new position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) in the third quarter, according to its most recent filing with the...

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?

BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioCryst Pharmaceuticals (BCRX) to Release Earnings on Thursday

BioCryst Pharmaceuticals (NASDAQ:BCRX) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

$BCRX Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $1.17 up 1000.00% YoY
• Reported revenue of $406.56M up 209.09% YoY
• BioCryst maintained full year 2026 global net ORLADEYO revenue guidance between $625M and $645M. BioCryst also maintained 2026 total revenue guidance between $635M and $660M.

Stocktwits

Biocryst Pharmaceuticals Inc.

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $1.17 up 1000.00% YoY
• Reported revenue of $406.56M up 209.09% YoY
• BioCryst maintained full year 2026 global net ORLADEYO revenue guidance between $625M and $645M. BioCryst also maintained 2026 total revenue guidance between $635M and $660M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Stocktwits Polls

The company announced robust Q4 2025 results with a $1.17 EPS, exceeding expectations, achieving profitability, and securing significant non-dilutive financing.

Active discussion surrounds over 40 million shares shorted and unusually high trading volume, leading many to speculate about an imminent short squeeze.

Traders are actively watching for a breakthrough past key resistance levels, with many forecasting a move towards $10 and higher targets up to $22 per share.

Optimism is building around the Navenibart program from the Astria acquisition and positive pediatric data for ORLADEYO, highlighting future growth potential.

BCRX
Biocryst Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest BCRX News

BCRXBiocryst Pharmaceuticals Inc.